92714-23-3Hyoscine Butylbromide EP Impurity G (Bromide Salt)

● In Stock

Catalogue No.:	VE0011422
CAS No.:	92714-23-3
Mol. Formula:	C21H28BrNO3
Mol. Weight:	422.36 g/mol

Request a quote

Add to RFQ list

Additional information on CAS 92714-23-3

Parent drug

Hyoscine Butylbromide

IUPAC Name

(1R, 2R, 4S, 5S, 7s, 9r)-9-Butyl-9-methyl-7-[(2-phenylprop-2-enoyl)oxy]-3-oxa-9-azoniatricyclo[3.3.1.02, 4]nonane bromide

Pharmacopoeial Synonyms

N/A

Other Synonyms

(9-butyl-9-methyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl) 2-phenylprop-2-enoate bromide; Apobuscopan

Smile

C=C(C1=CC=CC=C1)C(O[C@H]2C[C@@]3([H])[C@]4([H])O[C@]4([H])[C@@]([N@@+]3(CCCC)C)([H])C2)=O.[Br-]

InChI

InChI=1S/C21H28NO3.BrH/c1-4-5-11-22(3)17-12-16(13-18(22)20-19(17)25-20)24-21(23)14(2)15-9-7-6-8-10-15;/h6-10,16-20H,2,4-5,11-13H2,1,3H3;1H/q+1;/p-1/t16-,17-,18+,19-,20+,22+;

Description

Hyoscine Butylbromide EP Impurity G (Bromide Salt, also known as (9-butyl-9-methyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl) 2-phenylprop-2-enoate bromide ;Apobuscopan is a highly characterized reference material. It fully complies with stringent regulatory standards, including those set by USP, EMA, JP, and BP. This product is essential for use in Abbreviated New Drug Applications (ANDA), New Drug Applications (NDA), and the commercial production of Hyoscine Butylbromide. Moreover, it comes with a detailed Structure Elucidation Report (SER), ensuring its accuracy and reliability for a wide range of analytical applications.